| Application no. and date | 14786421.9 (espacenet) (Federated) (European Patent Register), 20141006 | | Patent/reg. no. and date | DK/EP 3054926, 20180725 | | Publication date | 20160817 | | Priority no. and date | US 201361887574 P, 20131007 | | EP pub. no. and date |
EP 3054926 20160817 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | V145837 | | Inventor | NIKFAR, Faranak, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
KOO, Otilia May Yue, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
TAO, Jing, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
KOTTALA, Niranjan Kumar, Flat 502 PVR Grand Apt. Simon Nagar
Kurmannapalem
Visakhapatnam
AP 530056, IN,
VARIA, Sailesh A., c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 9/24 (2006.01) | | Title | FORMULERING AF ATAZANAVIR OG COBICISTAT TIL HIV-BEHANDLING | | Int. application no. | US2014059310 | | Int. publication no. | WO2015054133 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
